The concept is striking because chronological age and biological age are not always the same. Chronological age is simply the number of years a person has lived, while biological age reflects the condition and functioning of cells and tissues. Scientists estimate biological age using molecular markers, including epigenetic changes. These changes do not alter the DNA sequence itself. Instead, they influence how genes are switched on or off, often through chemical modifications such as DNA methylation, in which small molecular groups attach to specific regions of DNA.

DNA methylation patterns change across the lifespan in partly predictable ways. By examining these patterns, researchers can calculate an epigenetic age estimate and compare it with a person’s actual age. When the estimated biological age is higher than the chronological age, researchers may describe the difference as accelerated or premature epigenetic aging. This does not mean that an individual is inevitably destined to develop disease early, but it may indicate that the body has been exposed to biological processes associated with faster aging.

The new research focuses on young adulthood, a period when the brain is still undergoing important structural and functional refinement. Although childhood and adolescence are often considered the central stages of brain development, neural maturation continues into the twenties. During this period, the brain reorganizes connections between regions, improves the efficiency of communication networks, and strengthens systems involved in planning, attention, working memory, decision-making and emotional regulation.

Pelant and colleagues examined the relationship between epigenetic aging and deviations from normative brain development. Normative modeling is a statistical approach that estimates how an individual’s brain compares with expected patterns observed across a reference population. Instead of asking only whether a brain measure is high or low, this method can identify whether a person’s brain structure or function falls outside the typical range for their age. Such deviations may reveal subtle differences that would be missed by conventional group comparisons.

According to the study’s focus, young adults with signs of premature epigenetic aging also showed differences in brain development relative to normative expectations. The findings suggest that accelerated biological aging may be reflected not only in molecular measurements taken from the body, but also in the way the brain’s development is organized. However, the relationship should not be interpreted as proof that epigenetic aging directly causes altered brain development. The study is examining associations, and many biological, psychological, environmental and lifestyle factors may influence both outcomes.

The researchers also investigated cognitive performance, bringing the findings closer to questions that matter in everyday life. Cognitive abilities depend on distributed networks rather than a single brain region. Attention, memory, processing speed and executive functions emerge from the coordinated activity of multiple systems. If brain development deviates from age-related expectations, those differences may be associated with measurable variation in how efficiently a person performs cognitive tasks. The study therefore adds a functional dimension to the molecular and neuroimaging evidence.

The implications are potentially significant because young adulthood is often viewed as a period of peak health, yet it may already contain detectable differences in biological aging. If epigenetic measures, brain-based normative models and cognitive testing can be combined reliably, scientists may eventually develop more sensitive ways to identify individuals whose development is progressing along an atypical trajectory. Such tools could support earlier research into prevention and could help clarify how stress, sleep, nutrition, physical activity, mental health and other exposures interact with biological aging.

At the same time, the findings should be understood as an emerging piece of evidence rather than a diagnostic test or a prediction of an individual’s future. Epigenetic clocks can vary according to the tissues analyzed, the molecular algorithms used and the population in which they were developed. Brain measurements are also influenced by technical factors, and cognitive scores can change with education, motivation, fatigue and testing conditions. Long-term studies will be needed to determine whether premature epigenetic aging and atypical brain development persist over time, whether they can be modified, and how strongly they predict later health or cognitive outcomes.

The study’s broader message is that aging may begin as a subtle, multidimensional process long before visible symptoms appear. Molecular biology, brain imaging and cognitive science are increasingly being combined to map that process in greater detail. By linking epigenetic age with brain-development patterns and performance in young adults, the research opens a provocative window onto why people of the same chronological age can differ biologically—and why those differences may matter for the brain.

Subject of Research: Premature epigenetic aging, normative brain development, and cognitive performance in young adulthood

Article Title: Premature epigenetic aging, deviations from normative brain development, and cognitive performance in young adulthood

Article References: Pelant, L., Marecek, R., Pačínková, A. et al. “Premature epigenetic aging, deviations from normative brain development, and cognitive performance in young adulthood.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04337-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04337-3

Keywords: epigenetic aging, biological age, brain development, normative modeling, cognitive performance, young adulthood, DNA methylation, neuroscience, Translational Psychiatry

Psychiatric conditions have increasingly been interpreted through a neurodevelopmental lens, suggesting that genetic liability does not act in isolation but interacts dynamically with environmental exposures throughout life. These interactions sculpt the neurological and behavioral trajectories that either predispose individuals to mental illness or foster resilience. However, capturing these varied trajectories requires extensive, long-term cohort studies that follow participants through pivotal developmental windows, a niche PARAM is uniquely positioned to fill with its expansive timeline and comprehensive methodology.

PARAM builds upon the legacy of the Consortium on the Vulnerability to Externalizing Disorders and Addictions (cVEDA), which previously recruited over 9,000 participants aged 6–23 years across India. By extending recruitment to encompass the fetal stage and early childhood up to 30 years of age, PARAM enhances the granularity of data collection, enabling researchers to trace developmental trajectories from the earliest stages of life. This extension is critical, as the fetal and early childhood periods are profoundly formative for neurodevelopment and later mental health outcomes.

Operating across eight diverse sites in India, the PARAM study boasts a geographically and socio-culturally heterogeneous sample that bolsters the generalizability of its findings. Five of these sites actively recontact participants from the initial cVEDA cohort, integrating longitudinal follow-ups with newly enrolled younger participants. This dual approach—closed cohort for infants and accelerated longitudinal design for older age groups—allows for robust modeling of developmental changes and risk trajectories over time.

Data collection in PARAM is strikingly comprehensive, encompassing repeated assessments that span psychometric questionnaires focused on development, temperament, and mental health, as well as detailed family histories to unravel hereditary influences. Environmental factors are rigorously quantified, capturing adverse experiences, maternal stress, dietary patterns, toxic exposures, and screen time, alongside objective satellite-derived metrics of urbanization and air pollution. These multifaceted data streams capture the environmental milieu that modulates genetic risks and neurodevelopment.

Beyond questionnaires and environmental data, PARAM employs a rich array of neurobiological and physiological assessments. Participants undergo anthropometric measurements, precise body composition analyses, and neurocognitive testing to profile cognitive trajectories. Neurophysiological markers, including heart rate variability and postural sway, offer insights into autonomic and sensorimotor function, while advanced neuroimaging with 3T MRI and functional near-infrared spectroscopy (fNIRS) permits in-depth examination of brain structure and function.

Crucially, the project integrates extensive biospecimen collection, including blood, buccal swabs, hair, nails, urine, and stool. These biological samples facilitate genomic, toxicological, and metabolic evaluations essential for dissecting the biological substrates of risk and resilience. A state-of-the-art digital archive harmonizes these diverse data types and links them to a barcoded biorepository, ensuring meticulous data management and enabling future multi-omic integrative analyses.

Analytically, PARAM is designed to leverage sophisticated statistical frameworks capable of handling complex, longitudinal, and multi-level data. Mixed-effects and generalized additive models will chart developmental trajectories while imaging harmonization protocols will enable normative modeling across diverse sites. Advanced integrative techniques will reconcile multi-omic and neuroimaging datasets to untangle the biological underpinnings of resilience and vulnerability, guided by predictive modeling approaches that employ nested cross-validation and external validation to ensure the robustness of findings.

Addressing the challenges of missing data and participant attrition, inherent in long-term cohort studies, PARAM employs multiple imputation strategies and inverse probability weighting to minimize bias and maintain statistical power. This rigorous approach underscores the project’s commitment to methodological excellence and the reliability of its outcomes.

The implications of PARAM are profound. By mapping population-based developmental trajectories in a socio-culturally rich context, it can identify modifiable risk and protective factors with potential for intervention. These insights may pave the way for precision mental health strategies tailored to the individual’s unique biological and environmental context, shifting psychiatry towards more predictive and preventative paradigms.

Moreover, the project’s broad scope and richly phenotyped dataset contribute a globally valuable resource to mental health research, particularly by filling a critical gap with data from low- and middle-income countries, often underrepresented in psychiatric genomics and neurodevelopmental studies. The diverse Indian population offers an unparalleled opportunity to explore how sociocultural and environmental heterogeneity shapes mental health outcomes.

Ultimately, PARAM stands as a pioneering effort to unravel the developmental pathways underlying mental health and resilience. It promises to push the frontiers of psychiatric research by integrating cutting-edge neuroscience, epidemiology, and multi-omic technologies within a uniquely diverse and large-scale cohort. The discoveries arising from this cohort hold the promise of transforming public mental health policies and clinical approaches, delivering more effective, contextsensitive mental health care across populations.

As psychiatric science continues to evolve, the PARAM study exemplifies the shift towards life-course, integrative perspectives that recognize the individual’s developmental context as critical. Its findings are anticipated to catalyze new hypotheses, inform intervention timing, and highlight environmental policies that mitigate risk factors such as pollution and stress. The PARAM project thus represents not only a scientific milestone but also a beacon for public mental health advancement in India and beyond.

This groundbreaking endeavor underscores the power of collaborative, multi-site research networks and digital biorepositories in advancing precision psychiatry. As the data from PARAM mature and analyses unfold, the scientific and medical communities eagerly await insights that may redefine paradigms of resilience, risk, and recovery in mental health, promising a future where tailored interventions can mitigate the burden of psychiatric disorders globally.

Subject of Research: Developmental trajectories of resilience and mental health across the lifespan, genetic and environmental factors influencing psychiatric outcomes, multi-omic and neuroimaging integration in a large Indian cohort

Article Title: The PAthways to Resilience And Mental health (PARAM) project: protocol for a multi-site developmental cohort in India

Article References:
Holla, B., Sharma, E., Venkataramanan, S. et al. The PAthways to Resilience And Mental health (PARAM) project: protocol for a multi-site developmental cohort in India. BMC Psychiatry 25, 1051 (2025). https://doi.org/10.1186/s12888-025-07492-x

Image Credits: AI Generated

DOI: 10.1186/s12888-025-07492-x